271 related articles for article (PubMed ID: 11486553)
1. [Fluoroquinolones--a current review].
Christ W; Kemmler H
Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553
[No Abstract] [Full Text] [Related]
2. Fluoroquinolone resistance: mechanisms and epidemiology.
Tillotson GS; Dorrian I; Blondeau J
J Med Microbiol; 1997 Jun; 46(6):457-61. PubMed ID: 9379475
[No Abstract] [Full Text] [Related]
3. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
Naumann P; Dopp C
Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
[No Abstract] [Full Text] [Related]
4. Fluoroquinolones.
Molavi A
Am Fam Physician; 1988 May; 37(5):279-84. PubMed ID: 3284309
[No Abstract] [Full Text] [Related]
5. Trovafloxacin: fourth generation fluoroquinolone.
McNabb J; Nicolau D; Quintiliani R; Nightingale C
Conn Med; 1998 Aug; 62(8):483-7. PubMed ID: 9753805
[No Abstract] [Full Text] [Related]
6. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
Stahlmann R; Lode H
MMW Fortschr Med; 1999 Nov; 141(47):35-6. PubMed ID: 10912165
[No Abstract] [Full Text] [Related]
7. [Tosufloxacin tosilate].
Shimada K
Jpn J Antibiot; 1990 Apr; 43(4):583-602. PubMed ID: 2199687
[No Abstract] [Full Text] [Related]
8. [Quinolones. Gyrase inhibitors].
Höffler D
Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
[No Abstract] [Full Text] [Related]
9. [Therapeutic use of fluoroquinolones].
Lumio J
Duodecim; 1999; 115(3):304-15. PubMed ID: 11830877
[No Abstract] [Full Text] [Related]
10. [The rational use of fluoroquinolones].
Zhang Y
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):7-8. PubMed ID: 12795261
[No Abstract] [Full Text] [Related]
11. Appropriate antibiotic use: reducing the emergence and dissemination of resistance.
Low DE
Int J Clin Pract Suppl; 2000 Dec; (115):106-10. PubMed ID: 11219292
[No Abstract] [Full Text] [Related]
12. [Trovafloxacin].
Azanza JR; Ollero D; Sádaba B; García Quetglas E
Rev Med Univ Navarra; 1999; 43(1):45-57. PubMed ID: 10386346
[No Abstract] [Full Text] [Related]
13. [Bacterial enteropathogens and antimicrobial resistance in Zamora: the usefulness of fluoroquinolones].
Canut Blasco A; Brezmes Valdivieso MF; Rodríquez Hernández J; Conde Martín ML
Med Clin (Barc); 1993 Apr; 100(14):557-9. PubMed ID: 8469047
[No Abstract] [Full Text] [Related]
14. [The place of fluoroquinolones in the treatment of bacterial infections].
Iakovlev SV
Antibiot Khimioter; 1999; 44(12):27-30. PubMed ID: 10687031
[No Abstract] [Full Text] [Related]
15. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
Aarestrup FM; Jensen NE; Jorsal SE; Nielsen TK
Vet Rec; 2000 Jan; 146(3):76-8. PubMed ID: 10674696
[No Abstract] [Full Text] [Related]
16. [Fluoroquinolones--current value in antibacterial therapy, outlook for development].
Navashin SM; Navashin PS
Antibiot Khimioter; 1996; 41(9):4-10. PubMed ID: 9005784
[No Abstract] [Full Text] [Related]
17. Challenges in pharmacodynamic studies of antimicrobial resistance.
Rapp RP; Campion JJ
Ann Pharmacother; 2003 Sep; 37(9):1329-30. PubMed ID: 12921518
[No Abstract] [Full Text] [Related]
18. [Which partner for the betalactam agent in empiric combined therapy? I Fluoroquinolone].
Bedos JP
Ann Fr Anesth Reanim; 2004 Jun; 23(6):636-8. PubMed ID: 15234734
[No Abstract] [Full Text] [Related]
19. Pharmacokinetic and clinical studies of T-3761 in otorhinolaryngeal infections.
Shinkawa A; Kimura H; Sakai M; Miyake H
Drugs; 1995; 49 Suppl 2():401-2. PubMed ID: 8549377
[No Abstract] [Full Text] [Related]
20. Quinolones: which generation for which microbe?
Lee MK; Kanatani MS
West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
